These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38151855)

  • 21. A unique combination of inhibitory and partially activating mutations in beta3 of a patient with variant-type Glanzmann thrombasthenia.
    Nurden AT; Fernandes H; Fiore M; Nurden P; Vinciguerra C; Martins N; Sirvain-Trukniewicz P; Couloux A; Heilig R; Pillois X
    Platelets; 2010; 21(6):498-500. PubMed ID: 20438394
    [No Abstract]   [Full Text] [Related]  

  • 22. A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia.
    Guillet B; Bayart S; Pillois X; Nurden P; Caen JP; Nurden AT
    J Thromb Haemost; 2019 Dec; 17(12):2211-2215. PubMed ID: 31565851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
    Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
    Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
    Nurden AT; Fiore M; Nurden P; Pillois X
    Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interesting variations on how a disease is defined: comparisons of von Willebrand disease and Glanzmann thrombasthenia.
    Nurden AT
    J Thromb Haemost; 2007 Mar; 5(3):647-9; author reply 649-51. PubMed ID: 17166245
    [No Abstract]   [Full Text] [Related]  

  • 27. Carrier detection in Glanzmann thrombasthenia: comparison of flow cytometry and Western blot with respect to DNA mutation.
    Kannan M; Ahmad F; Yadav BK; Kumar P; Jain P; Kumar R; Saxena R
    Am J Clin Pathol; 2008 Jul; 130(1):93-8. PubMed ID: 18550477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of c.1431C > T mutation, a causative mutation of Glanzmann's thrombasthenia, on ITGB3 splicing, gene and protein expression.
    Wang D; Lai P; Lu Q; El-Magd MA; Li X
    Gene; 2023 Dec; 888():147805. PubMed ID: 37716584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glanzmann thrombasthenia: genetic basis and clinical correlates.
    Botero JP; Lee K; Branchford BR; Bray PF; Freson K; Lambert MP; Luo M; Mohan S; Ross JE; Bergmeier W; Di Paola J;
    Haematologica; 2020 Apr; 105(4):888-894. PubMed ID: 32139434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against α
    Fiore M; Bayat B; Phuangtham R; Blouin L; Huguenin Y; Bein G; Santoso S
    J Thromb Haemost; 2021 Jan; 19(1):255-261. PubMed ID: 33090654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two different beta3 cysteine substitutions alter alphaIIb beta3 maturation and result in Glanzmann thrombasthenia.
    Milet-Marsal S; Breillat C; Peyruchaud O; Nurden P; Combrié R; Nurden A; Bourre F
    Thromb Haemost; 2002 Jul; 88(1):104-10. PubMed ID: 12152649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.
    Bury L; Falcinelli E; Chiasserini D; Springer TA; Italiano JE; Gresele P
    Haematologica; 2016 Jan; 101(1):46-56. PubMed ID: 26452979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.
    Laguerre M; Sabi E; Daly M; Stockley J; Nurden P; Pillois X; Nurden AT
    PLoS One; 2013; 8(11):e78683. PubMed ID: 24236036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced collagen-induced platelet aggregation in obligate heterozygotes of a Glanzmann thrombasthenia variant with a beta 3 mutation.
    Nurden A; Jacquelin B; Tuleja E; Combrié R; Nurden P
    Thromb Haemost; 2002 Aug; 88(2):364-5. PubMed ID: 12195716
    [No Abstract]   [Full Text] [Related]  

  • 35. No genetic abnormalities identified in α2IIb and β3: phenotype overcomes genotype in Glanzmann thrombasthenia.
    Kannan M; Saxena R
    Int J Lab Hematol; 2017 Apr; 39(2):e41-e44. PubMed ID: 27808476
    [No Abstract]   [Full Text] [Related]  

  • 36. Integrin β3 Deficiency Results in Hypertriglyceridemia via Disrupting LPL (Lipoprotein Lipase) Secretion.
    Xiao B; Mao J; Sun B; Zhang W; Wang Y; Wang P; Ruan Z; Xi W; Li H; Zhou J; Lu Y; Ding Q; Wang X; Liu J; Yan J; Luo C; Shi X; Yang R; Xi X
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1296-1310. PubMed ID: 32237906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia.
    Kannan M; Ahmad F; Yadav BK; Kumar R; Choudhry VP; Saxena R
    J Thromb Haemost; 2009 Nov; 7(11):1878-85. PubMed ID: 19691478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.
    Morais S; Oliveira J; Lau C; Pereira M; Gonçalves M; Monteiro C; Gonçalves AR; Matos R; Sampaio M; Cruz E; Freitas I; Santos R; Lima M
    PLoS One; 2020; 15(12):e0235136. PubMed ID: 33276370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I Glanzmann thrombasthenia caused by an apparently silent beta3 mutation that results in aberrant splicing and reduced beta3 mRNA.
    Xie J; Pabón D; Jayo A; Butta N; González-Manchón C
    Thromb Haemost; 2005 May; 93(5):897-903. PubMed ID: 15886806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.